Literature DB >> 16130989

Use of fine needle aspirates and flow cytometry for the diagnosis, classification, and immunophenotyping of canine lymphomas.

Mahmut Sözmen1, Silvia Tasca, Erika Carli, Davide De Lorenzi, Tommaso Furlanello, Marco Caldin.   

Abstract

Fifty canine lymphomas were classified cytomorphologically using the updated Kiel classification scheme. Aspirates of lymph nodes from dogs with lymphoma were stained using 5 canine-specific antibodies and 3 human-specific antibodies that cross-react with canine lymphocytes. The antibody-stained aspirates were analyzed by flow cytometry. A total of 32 (64%) of the 50 lymphomas were characterized as B-cell origin and 18 (36%) were of T-cell origin. B-cell lymphomas were identified in 12 females and 20 males with a mean age of 8.35 years. T-cell lymphomas were identified in 8 females and 10 males with a mean age of 7.9 years. A minority of the lymphomas were low-grade B-cell and T-cell lymphomas (6/50, 12% and 4/50, 8%, respectively). The most common morphologic types were high-grade centroblastic and unclassifiable plasmacytoid for B- and T-cell lymphomas (18/50, 36% and 7/50, 14%, respectively).

Entities:  

Mesh:

Year:  2005        PMID: 16130989     DOI: 10.1177/104063870501700404

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  9 in total

1.  Tumor staging in a Beagle dog with concomitant large B-cell lymphoma and T-cell acute lymphoblastic leukemia.

Authors:  Alessandro Ferrari; Marzia Cozzi; Luca Aresu; Valeria Martini
Journal:  J Vet Diagn Invest       Date:  2021-04-22       Impact factor: 1.279

2.  Rapid, effective and user-friendly immunophenotyping of canine lymphoma using a personal flow cytometer.

Authors:  Stratos Papakonstantinou; Inese Berzina; Amanda Lawlor; Emma J O'Neill; Peter J O'Brien
Journal:  Ir Vet J       Date:  2013-04-01       Impact factor: 2.146

3.  Application of flow cytometry in diagnosing lymphomas in dogs and cats.

Authors:  Olga Aniołek; Zdzisław Gajewski; Sławomir Giziński
Journal:  Cent Eur J Immunol       Date:  2014-10-14       Impact factor: 2.085

4.  Detection of clonal antigen receptor gene rearrangement in dogs with lymphoma by real-time polymerase chain reaction and melting curve analysis.

Authors:  Kathrin F A Langner; Alexa E Joetzke; Verena Nerschbach; Nina Eberle; Hans-Joachim Schuberth; Mirja Koy; Ingo Nolte; Daniela Betz
Journal:  BMC Vet Res       Date:  2014-01-03       Impact factor: 2.741

5.  Breed prevalence of canine lymphoma in South Africa.

Authors:  Liesl J Van Rooyen; Emma Hooijberg; Fred Reyers
Journal:  J S Afr Vet Assoc       Date:  2018-03-08       Impact factor: 1.474

6.  Global DNA methylation of peripheral blood leukocytes from dogs bearing multicentric non-Hodgkin lymphomas and healthy dogs: A comparative study.

Authors:  Tatiane Moreno Ferrarias Epiphanio; Natália Coelho Couto de Azevedo Fernandes; Tiago Franco de Oliveira; Priscila Assis Lopes; Rodrigo Albergaria Réssio; Simone Gonçalves; Náyra Villar Scattone; Marcello Vannucci Tedardi; Leslie Domenici Kulikowski; Jullian Damasceno; Ana Paula de Melo Loureiro; Maria Lucia Zaidan Dagli
Journal:  PLoS One       Date:  2019-03-25       Impact factor: 3.240

7.  Demographic and clinical characteristics of dogs with centroblastic lymphoma.

Authors:  Katarzyna Kliczkowska-Klarowicz; Dariusz Jagielski; Michał Czopowicz; Rafał A Sapierzyński
Journal:  Vet World       Date:  2021-01-07

8.  Prognostic analyses on anatomical and morphological classification of feline lymphoma.

Authors:  Hirofumi Sato; Yasuhito Fujino; Junko Chino; Masashi Takahashi; Kenjiro Fukushima; Yuko Goto-Koshino; Kazuyuki Uchida; Koichi Ohno; Hajime Tsujimoto
Journal:  J Vet Med Sci       Date:  2014-02-10       Impact factor: 1.267

9.  Flow cytometric characterization and clinical outcome of CD4+ T-cell lymphoma in dogs: 67 cases.

Authors:  P R Avery; J Burton; J L Bromberek; D M Seelig; R Elmslie; S Correa; E J Ehrhart; P S Morley; A C Avery
Journal:  J Vet Intern Med       Date:  2014-02-03       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.